Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000387693

Medchemexpress LLC Purvalanol B (NG 95) | 212844-54-7 | 97.0% | 432.90 | 200 MG
SDP

Catalog No. 5000387693
Encompass_Preferred

Purvalanol B (NG 95) is a potent, selective, reversible, and ATP-competitive inhibitor of cyclin-dependent kinases (CDK). It demonstrates significant selectivity for CDK over other protein kinases and effectively inhibits the growth of a chloroquine-resistant strain of *P. falciparum*.

  • Potent, selective, reversible, and ATP-competitive inhibitor of CDK
  • Inhibits cdc2-cyclin B, CDK2-cyclin A, and CDK5-p35 with IC50s of 6 nM
  • Inhibits CDK2-cyclin E with an IC50 of 9 nM
  • Shows selectivity for CDK over other protein kinases (IC50 > 1000 nM)
  • Inhibits the growth of a chloroquine-resistant strain of *P. falciparum*

Catalog No. 50-003-87693 Supplier Medchemexpress LLC Supplier No. HY18299200MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Purvalanol B (NG 95) is a potent, selective, reversible, and ATP-competitive inhibitor of cyclin-dependent kinases (CDK). It demonstrates significant selectivity for CDK over other protein kinases and effectively inhibits the growth of a chloroquine-resistant strain of *P. falciparum*.

  • Potent, selective, reversible, and ATP-competitive inhibitor of CDK
  • Inhibits cdc2-cyclin B, CDK2-cyclin A, and CDK5-p35 with IC50s of 6 nM
  • Inhibits CDK2-cyclin E with an IC50 of 9 nM
  • Shows selectivity for CDK over other protein kinases (IC50 > 1000 nM)
  • Inhibits the growth of a chloroquine-resistant strain of *P. falciparum*

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.